Biliary excretion of polystyrene microspheres depends on the type of receptor-mediated uptake in rat liver.

[1]  M. Hashida,et al.  Interaction of polystyrene microspheres with liver cells: roles of membrane receptors and serum proteins. , 1999, Biochimica et biophysica acta.

[2]  M. Hashida,et al.  Mechanisms of hepatic disposition of polystyrene microspheres in rats: effects of serum depend on the sizes of microspheres. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[3]  M. Hashida,et al.  Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[4]  M. Hashida,et al.  Liver uptake and hepato-biliary transfer of galactosylated proteins in rats are determined by the extent of galactosylation. , 1999, Biochimica et biophysica acta.

[5]  M. Hashida,et al.  Uptake by hepatocytes and biliary excretion of intravenously administered polystyrene microspheres in rats. , 1999, Journal of drug targeting.

[6]  D. McAbee,et al.  Identification and isolation of a 45-kDa calcium-dependent lactoferrin receptor from rat hepatocytes. , 1997, Biochemistry.

[7]  M. Hashida,et al.  Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine). , 1997, Biochemical pharmacology.

[8]  T. V. van Berkel,et al.  Recognition of lactoferrin and aminopeptidase M-modified lactoferrin by the liver: involvement of proteoglycans and the remnant receptor. , 1994, The Biochemical journal.

[9]  Dexi Liu,et al.  Recognition and clearance of liposomes containing phosphatidylserine are mediated by serum opsonin. , 1995, Biochimica et biophysica acta.

[10]  J. K. Kruijt,et al.  Selective liver targeting of antivirals by recombinant chylomicrons — a new therapeutic approach to hepatitis B , 1995, Nature Medicine.

[11]  J. Burgess,et al.  17 alpha-ethinylestradiol increases transcytosis of asialoglycoproteins in rat liver. , 1994, The Journal of biological chemistry.

[12]  K. Funato,et al.  The complement- but not mannose receptor-mediated phagocytosis is involved in the hepatic uptake of cetylmannoside-modified liposomes in situ. , 1994, Journal of drug targeting.

[13]  L. Illum,et al.  Influence of block copolymers on the adsorption of plasma proteins to microspheres. , 1993, Biomaterials.

[14]  M. Brown,et al.  Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. , 1992, The Journal of biological chemistry.

[15]  V. Kolb‐Bachofen.  Uptake of toxic silica particles by isolated rat liver macrophages (Kupffer cells) is receptor mediated and can be blocked by competition. , 1992, The Journal of clinical investigation.

[16]  D. Herbert,et al.  Evidence that hepatocytes can phagocytize exogenous substances , 1992, The Anatomical record.

[17]  L. Huang,et al.  Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. , 1992, Biochimica et biophysica acta.

[18]  D. Knook,et al.  Rat liver endothelial cells have a greater capacity than kupffer cells to endocytose N‐acetylglucosamine‐ and mannose‐terminated glycoproteins , 1987, Hepatology.

[19]  A. Jones,et al.  Human IgA as a heterovalent ligand: switching from the asialoglycoprotein receptor to secretory component during transport across the rat hepatocyte , 1986, The Journal of cell biology.

[20]  M. M. Fisher,et al.  Receptor-mediated biliary transport of immunoglobulin A and asialoglycoprotein: sorting and missorting of ligands revealed by two radiolabeling methods , 1984, The Journal of cell biology.

[21]  E. Regoeczi,et al.  Receptor-rich intracellular membrane vesicles transporting asialotransferrin and insulin in liver , 1982, Nature.

[22]  H. Bazin,et al.  Identification of secretory component as an IgA receptor on rat hepatocytes , 1979, The Journal of experimental medicine.